Pre-order Enquiry
Request Free Sample
Global Alcohol Addiction Therapeutics Market Research Report 2021
SKU ID : QYR-17230710 | Publishing Date : 18-Jan-2021 | No. of pages : 122
Detailed TOC of Global Alcohol Addiction Therapeutics Market Research Report 2021
1 Alcohol Addiction Therapeutics Market Overview1.1 Product Overview and Scope of Alcohol Addiction Therapeutics
1.2 Alcohol Addiction Therapeutics Segment by Type
1.2.1 Global Alcohol Addiction Therapeutics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 CM-1212
1.2.3 CTDP-002
1.2.4 A-705253
1.2.5 ABT-436
1.2.6 ADX-71441
1.2.7 Others
1.3 Alcohol Addiction Therapeutics Segment by Application
1.3.1 Alcohol Addiction Therapeutics Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Alcohol Addiction Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Alcohol Addiction Therapeutics Revenue 2016-2027
1.4.2 Global Alcohol Addiction Therapeutics Sales 2016-2027
1.4.3 Alcohol Addiction Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Alcohol Addiction Therapeutics Market Competition by Manufacturers
2.1 Global Alcohol Addiction Therapeutics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Alcohol Addiction Therapeutics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Alcohol Addiction Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 Alcohol Addiction Therapeutics Market Competitive Situation and Trends
2.5.1 Alcohol Addiction Therapeutics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Alcohol Addiction Therapeutics Players Market Share by Revenue
2.5.3 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alcohol Addiction Therapeutics Retrospective Market Scenario by Region
3.1 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Alcohol Addiction Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Alcohol Addiction Therapeutics Market Facts & Figures by Country
3.3.1 North America Alcohol Addiction Therapeutics Sales by Country
3.3.2 North America Alcohol Addiction Therapeutics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Alcohol Addiction Therapeutics Market Facts & Figures by Country
3.4.1 Europe Alcohol Addiction Therapeutics Sales by Country
3.4.2 Europe Alcohol Addiction Therapeutics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Alcohol Addiction Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific Alcohol Addiction Therapeutics Sales by Region
3.5.2 Asia Pacific Alcohol Addiction Therapeutics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Alcohol Addiction Therapeutics Market Facts & Figures by Country
3.6.1 Latin America Alcohol Addiction Therapeutics Sales by Country
3.6.2 Latin America Alcohol Addiction Therapeutics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Alcohol Addiction Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa Alcohol Addiction Therapeutics Sales by Country
3.7.2 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Alcohol Addiction Therapeutics Historic Market Analysis by Type
4.1 Global Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2021)
4.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2016-2021)
4.3 Global Alcohol Addiction Therapeutics Price by Type (2016-2021)
5 Global Alcohol Addiction Therapeutics Historic Market Analysis by Application
5.1 Global Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2021)
5.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2016-2021)
5.3 Global Alcohol Addiction Therapeutics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AstraZeneca Plc
6.1.1 AstraZeneca Plc Corporation Information
6.1.2 AstraZeneca Plc Description and Business Overview
6.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Plc Product Portfolio
6.1.5 AstraZeneca Plc Recent Developments/Updates
6.2 BioCorRx Inc
6.2.1 BioCorRx Inc Corporation Information
6.2.2 BioCorRx Inc Description and Business Overview
6.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BioCorRx Inc Product Portfolio
6.2.5 BioCorRx Inc Recent Developments/Updates
6.3 Bionex Pharmaceuticals LLC
6.3.1 Bionex Pharmaceuticals LLC Corporation Information
6.3.2 Bionex Pharmaceuticals LLC Description and Business Overview
6.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bionex Pharmaceuticals LLC Product Portfolio
6.3.5 Bionex Pharmaceuticals LLC Recent Developments/Updates
6.4 Cerecor Inc
6.4.1 Cerecor Inc Corporation Information
6.4.2 Cerecor Inc Description and Business Overview
6.4.3 Cerecor Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cerecor Inc Product Portfolio
6.4.5 Cerecor Inc Recent Developments/Updates
6.5 Chronos Therapeutics Ltd
6.5.1 Chronos Therapeutics Ltd Corporation Information
6.5.2 Chronos Therapeutics Ltd Description and Business Overview
6.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Chronos Therapeutics Ltd Product Portfolio
6.5.5 Chronos Therapeutics Ltd Recent Developments/Updates
6.6 Corcept Therapeutics Inc
6.6.1 Corcept Therapeutics Inc Corporation Information
6.6.2 Corcept Therapeutics Inc Description and Business Overview
6.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Corcept Therapeutics Inc Product Portfolio
6.6.5 Corcept Therapeutics Inc Recent Developments/Updates
6.7 Curemark LLC
6.6.1 Curemark LLC Corporation Information
6.6.2 Curemark LLC Description and Business Overview
6.6.3 Curemark LLC Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Curemark LLC Product Portfolio
6.7.5 Curemark LLC Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Corporation Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Eli Lilly and Company Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 Ethypharm SA
6.9.1 Ethypharm SA Corporation Information
6.9.2 Ethypharm SA Description and Business Overview
6.9.3 Ethypharm SA Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Ethypharm SA Product Portfolio
6.9.5 Ethypharm SA Recent Developments/Updates
6.10 H. Lundbeck A/S
6.10.1 H. Lundbeck A/S Corporation Information
6.10.2 H. Lundbeck A/S Description and Business Overview
6.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 H. Lundbeck A/S Product Portfolio
6.10.5 H. Lundbeck A/S Recent Developments/Updates
6.11 Heptares Therapeutics Ltd
6.11.1 Heptares Therapeutics Ltd Corporation Information
6.11.2 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Description and Business Overview
6.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Heptares Therapeutics Ltd Product Portfolio
6.11.5 Heptares Therapeutics Ltd Recent Developments/Updates
6.12 Indivior Plc
6.12.1 Indivior Plc Corporation Information
6.12.2 Indivior Plc Alcohol Addiction Therapeutics Description and Business Overview
6.12.3 Indivior Plc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Indivior Plc Product Portfolio
6.12.5 Indivior Plc Recent Developments/Updates
6.13 Kinnov Therapeutics SAS
6.13.1 Kinnov Therapeutics SAS Corporation Information
6.13.2 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Description and Business Overview
6.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Kinnov Therapeutics SAS Product Portfolio
6.13.5 Kinnov Therapeutics SAS Recent Developments/Updates
6.14 Kyorin Pharmaceutical Co Ltd
6.14.1 Kyorin Pharmaceutical Co Ltd Corporation Information
6.14.2 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Description and Business Overview
6.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Kyorin Pharmaceutical Co Ltd Product Portfolio
6.14.5 Kyorin Pharmaceutical Co Ltd Recent Developments/Updates
6.15 Lohocla Research Corp
6.15.1 Lohocla Research Corp Corporation Information
6.15.2 Lohocla Research Corp Alcohol Addiction Therapeutics Description and Business Overview
6.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Lohocla Research Corp Product Portfolio
6.15.5 Lohocla Research Corp Recent Developments/Updates
6.16 Montisera Ltd
6.16.1 Montisera Ltd Corporation Information
6.16.2 Montisera Ltd Alcohol Addiction Therapeutics Description and Business Overview
6.16.3 Montisera Ltd Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Montisera Ltd Product Portfolio
6.16.5 Montisera Ltd Recent Developments/Updates
6.17 Omeros Corp
6.17.1 Omeros Corp Corporation Information
6.17.2 Omeros Corp Alcohol Addiction Therapeutics Description and Business Overview
6.17.3 Omeros Corp Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Omeros Corp Product Portfolio
6.17.5 Omeros Corp Recent Developments/Updates
6.18 Opiant Pharmaceuticals Inc
6.18.1 Opiant Pharmaceuticals Inc Corporation Information
6.18.2 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Description and Business Overview
6.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Opiant Pharmaceuticals Inc Product Portfolio
6.18.5 Opiant Pharmaceuticals Inc Recent Developments/Updates
7 Alcohol Addiction Therapeutics Manufacturing Cost Analysis
7.1 Alcohol Addiction Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Alcohol Addiction Therapeutics
7.4 Alcohol Addiction Therapeutics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Alcohol Addiction Therapeutics Distributors List
8.3 Alcohol Addiction Therapeutics Customers
9 Alcohol Addiction Therapeutics Market Dynamics
9.1 Alcohol Addiction Therapeutics Industry Trends
9.2 Alcohol Addiction Therapeutics Growth Drivers
9.3 Alcohol Addiction Therapeutics Market Challenges
9.4 Alcohol Addiction Therapeutics Market Restraints
10 Global Market Forecast
10.1 Alcohol Addiction Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Alcohol Addiction Therapeutics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Alcohol Addiction Therapeutics by Type (2022-2027)
10.2 Alcohol Addiction Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Alcohol Addiction Therapeutics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Alcohol Addiction Therapeutics by Application (2022-2027)
10.3 Alcohol Addiction Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Alcohol Addiction Therapeutics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Alcohol Addiction Therapeutics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Alcohol Addiction Therapeutics Market Research Report 2021
List of TablesTable 1. Global Alcohol Addiction Therapeutics Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Alcohol Addiction Therapeutics Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Alcohol Addiction Therapeutics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Alcohol Addiction Therapeutics Covered in This Study
Table 5. Global Alcohol Addiction Therapeutics Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Alcohol Addiction Therapeutics Sales Share by Manufacturers (2016-2021)
Table 7. Global Alcohol Addiction Therapeutics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Alcohol Addiction Therapeutics Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Alcohol Addiction Therapeutics Manufacturing Sites and Area Served
Table 11. Manufacturers Alcohol Addiction Therapeutics Product Type
Table 12. Global Alcohol Addiction Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Alcohol Addiction Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcohol Addiction Therapeutics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Alcohol Addiction Therapeutics Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Alcohol Addiction Therapeutics Sales Market Share by Region (2016-2021)
Table 17. Global Alcohol Addiction Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Alcohol Addiction Therapeutics Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Alcohol Addiction Therapeutics Sales Market Share by Country (2016-2021)
Table 20. North America Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2021)
Table 22. Europe Alcohol Addiction Therapeutics Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Alcohol Addiction Therapeutics Sales Market Share by Country (2016-2021)
Table 24. Europe Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Alcohol Addiction Therapeutics Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Alcohol Addiction Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Alcohol Addiction Therapeutics Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Alcohol Addiction Therapeutics Sales Market Share by Country (2016-2021)
Table 32. Latin America Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Alcohol Addiction Therapeutics Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2021)
Table 38. Global Alcohol Addiction Therapeutics Sales (K Pcs) by Type (2016-2021)
Table 39. Global Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2021)
Table 40. Global Alcohol Addiction Therapeutics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Alcohol Addiction Therapeutics Revenue Share by Type (2016-2021)
Table 42. Global Alcohol Addiction Therapeutics Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Alcohol Addiction Therapeutics Sales (K Pcs) by Application (2016-2021)
Table 44. Global Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2021)
Table 45. Global Alcohol Addiction Therapeutics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Alcohol Addiction Therapeutics Revenue Share by Application (2016-2021)
Table 47. Global Alcohol Addiction Therapeutics Price (USD/Pcs) by Application (2016-2021)
Table 48. AstraZeneca Plc Corporation Information
Table 49. AstraZeneca Plc Description and Business Overview
Table 50. AstraZeneca Plc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AstraZeneca Plc Alcohol Addiction Therapeutics Product
Table 52. AstraZeneca Plc Recent Developments/Updates
Table 53. BioCorRx Inc Corporation Information
Table 54. BioCorRx Inc Description and Business Overview
Table 55. BioCorRx Inc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. BioCorRx Inc Alcohol Addiction Therapeutics Product
Table 57. BioCorRx Inc Recent Developments/Updates
Table 58. Bionex Pharmaceuticals LLC Corporation Information
Table 59. Bionex Pharmaceuticals LLC Description and Business Overview
Table 60. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product
Table 62. Bionex Pharmaceuticals LLC Recent Developments/Updates
Table 63. Cerecor Inc Corporation Information
Table 64. Cerecor Inc Description and Business Overview
Table 65. Cerecor Inc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Cerecor Inc Alcohol Addiction Therapeutics Product
Table 67. Cerecor Inc Recent Developments/Updates
Table 68. Chronos Therapeutics Ltd Corporation Information
Table 69. Chronos Therapeutics Ltd Description and Business Overview
Table 70. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product
Table 72. Chronos Therapeutics Ltd Recent Developments/Updates
Table 73. Corcept Therapeutics Inc Corporation Information
Table 74. Corcept Therapeutics Inc Description and Business Overview
Table 75. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product
Table 77. Corcept Therapeutics Inc Recent Developments/Updates
Table 78. Curemark LLC Corporation Information
Table 79. Curemark LLC Description and Business Overview
Table 80. Curemark LLC Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Curemark LLC Alcohol Addiction Therapeutics Product
Table 82. Curemark LLC Recent Developments/Updates
Table 83. Eli Lilly and Company Corporation Information
Table 84. Eli Lilly and Company Description and Business Overview
Table 85. Eli Lilly and Company Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Eli Lilly and Company Alcohol Addiction Therapeutics Product
Table 87. Eli Lilly and Company Recent Developments/Updates
Table 88. Ethypharm SA Corporation Information
Table 89. Ethypharm SA Description and Business Overview
Table 90. Ethypharm SA Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Ethypharm SA Alcohol Addiction Therapeutics Product
Table 92. Ethypharm SA Recent Developments/Updates
Table 93. H. Lundbeck A/S Corporation Information
Table 94. H. Lundbeck A/S Description and Business Overview
Table 95. H. Lundbeck A/S Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. H. Lundbeck A/S Alcohol Addiction Therapeutics Product
Table 97. H. Lundbeck A/S Recent Developments/Updates
Table 98. Heptares Therapeutics Ltd Corporation Information
Table 99. Heptares Therapeutics Ltd Description and Business Overview
Table 100. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product
Table 102. Heptares Therapeutics Ltd Recent Developments/Updates
Table 103. Indivior Plc Corporation Information
Table 104. Indivior Plc Description and Business Overview
Table 105. Indivior Plc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Indivior Plc Alcohol Addiction Therapeutics Product
Table 107. Indivior Plc Recent Developments/Updates
Table 108. Kinnov Therapeutics SAS Corporation Information
Table 109. Kinnov Therapeutics SAS Description and Business Overview
Table 110. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product
Table 112. Kinnov Therapeutics SAS Recent Developments/Updates
Table 113. Kyorin Pharmaceutical Co Ltd Corporation Information
Table 114. Kyorin Pharmaceutical Co Ltd Description and Business Overview
Table 115. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product
Table 117. Kyorin Pharmaceutical Co Ltd Recent Developments/Updates
Table 118. Lohocla Research Corp Corporation Information
Table 119. Lohocla Research Corp Description and Business Overview
Table 120. Lohocla Research Corp Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Lohocla Research Corp Alcohol Addiction Therapeutics Product
Table 122. Lohocla Research Corp Recent Developments/Updates
Table 123. Montisera Ltd Corporation Information
Table 124. Montisera Ltd Description and Business Overview
Table 125. Montisera Ltd Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Montisera Ltd Alcohol Addiction Therapeutics Product
Table 127. Montisera Ltd Recent Developments/Updates
Table 128. Omeros Corp Corporation Information
Table 129. Omeros Corp Description and Business Overview
Table 130. Omeros Corp Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Omeros Corp Alcohol Addiction Therapeutics Product
Table 132. Omeros Corp Recent Developments/Updates
Table 133. Opiant Pharmaceuticals Inc Corporation Information
Table 134. Opiant Pharmaceuticals Inc Description and Business Overview
Table 135. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product
Table 137. Opiant Pharmaceuticals Inc Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Alcohol Addiction Therapeutics Distributors List
Table 141. Alcohol Addiction Therapeutics Customers List
Table 142. Alcohol Addiction Therapeutics Market Trends
Table 143. Alcohol Addiction Therapeutics Growth Drivers
Table 144. Alcohol Addiction Therapeutics Market Restraints
Table 145. Global Alcohol Addiction Therapeutics Sales Forecast by Type (2022-2027) & (K Pcs)
Table 146. Global Alcohol Addiction Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 147. Global Alcohol Addiction Therapeutics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 148. Global Alcohol Addiction Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 149. Global Alcohol Addiction Therapeutics Sales Forecast by Application (2022-2027) & (K Pcs)
Table 150. Global Alcohol Addiction Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 151. Global Alcohol Addiction Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 152. Global Alcohol Addiction Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 153. Global Alcohol Addiction Therapeutics Sales Forecast by Region (2022-2027) & (K Pcs)
Table 154. Global Alcohol Addiction Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 155. Global Alcohol Addiction Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 156. Global Alcohol Addiction Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alcohol Addiction Therapeutics
Figure 2. Global Alcohol Addiction Therapeutics Market Share by Type in 2020 & 2027
Figure 3. CM-1212 Product Picture
Figure 4. CTDP-002 Product Picture
Figure 5. A-705253 Product Picture
Figure 6. ABT-436 Product Picture
Figure 7. ADX-71441 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Alcohol Addiction Therapeutics Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Alcohol Addiction Therapeutics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Alcohol Addiction Therapeutics Market Size 2016-2027 (US$ Million)
Figure 15. Global Alcohol Addiction Therapeutics Sales 2016-2027 (K Pcs)
Figure 16. Global Alcohol Addiction Therapeutics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Alcohol Addiction Therapeutics Sales Share by Manufacturers in 2020
Figure 18. Global Alcohol Addiction Therapeutics Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Alcohol Addiction Therapeutics Players: Market Share by Revenue in 2020
Figure 20. Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Alcohol Addiction Therapeutics Sales Market Share by Region (2016-2021)
Figure 22. Global Alcohol Addiction Therapeutics Sales Market Share by Region in 2020
Figure 23. Global Alcohol Addiction Therapeutics Revenue Market Share by Region (2016-2021)
Figure 24. Global Alcohol Addiction Therapeutics Revenue Market Share by Region in 2020
Figure 25. U.S. Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Alcohol Addiction Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Alcohol Addiction Therapeutics by Type (2016-2021)
Figure 50. Sales Market Share of Alcohol Addiction Therapeutics by Application (2016-2021)
Figure 51. Sales Market Share of Alcohol Addiction Therapeutics by Application in 2020
Figure 52. Revenue Share of Alcohol Addiction Therapeutics by Application (2016-2021)
Figure 53. Revenue Share of Alcohol Addiction Therapeutics by Application in 2020
Figure 54. Manufacturing Cost Structure of Alcohol Addiction Therapeutics
Figure 55. Manufacturing Process Analysis of Alcohol Addiction Therapeutics
Figure 56. Alcohol Addiction Therapeutics Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Keyplayers in Global Alcohol Addiction Therapeutics Market Research Report 2021
AstraZeneca PlcBioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc
Request Sample
Request Discount
